The Mystery of CloningJoin now to read essay The Mystery of CloningCloningCloning humans is banned in 23 countries. But scientists and researchers are pushing the technology because they believe that human cloning can bring the future with many benefits. In the United States, 4 states have banned human cloning and the law doesn’t allow any government funding for human cloning research. Researchers and scientists by declaring their intentions of human cloning have challenged many nations to ease up on human cloning for biomedical research. On January 22, 2001, Britain became the first to permit researchers to clone human embryos for medical research. Britain’s new law allows the researchers up to 14 days to experiment on human cloned embryos for medical research and permission should be granted only when it can be shown there are no other ways of meeting an experiment’s objectives. Now that Britain is opening the barriers for human cloning technology, other countries are beginning to follow Britain’s footsteps.
Why not clone? The issues of the immorality and unethical nature of cloning has made many people to downsize the technology. Clinton states that,” Any discovery that touches upon human creation is not simply a matter of scientific inquiry, it is a matter of morality and spirituality as well. Each human life is unique, born of a mistake that reaches beyond laboratory science.” Clinton, for that reason, stopped funding in human cloning research. From many religious philosophies, human cloning is against the will of god and denies the individuality of his or her uniqueness.
Other advocates of human cloning believe that cloning involves risks of abnormalities. Although animal cloning has been known a success, the numbers of animal cloning success has been quite unsuccessful. Many of the animal cloned pregnancies have grown abnormally. There have been 247 abnormal pregnancies out of one successful pregnancy. Most of the pregnancies result in severe abnormalities such as abnormal blood vessels and heart problems. Advocates are relating animal cloning to human cloning thus stating that human cloning can be risky.
Many researchers, however, believe differently from those advocates of human cloning. Most of the researchers believe that human cloning can be extremely beneficial to human kind. They believe that there are many benefits to human cloning that most people don’t know about. Cloned human embryos would help research in the fields of genetics and genetically related diseases. Researchers believe that by cloning a diseased or a genetically disorder embryo, it would give researchers the opportunity to experiment with the embryo instead of the individual with the disease or disorder. Experimenting on the embryo stem cell would open new doors on testing. Researching in this field could provide the future with means of treatments
Practicalities of Medical Science for Human Biomedicine:
To the best of my knowledge, there are no biomedical studies in human cloning in medical research centers, the medical research centers of academia and the medical research centers of healthcare system. We only have a limited number of research facilities that take a basic approach that includes the ability to provide human cloning as a science fact. Our research facilities rely on donations from the many citizens of our community, for example. This is in part due to the work of medical personnel to determine the safety, optimal method and technology for human cloning, and also due to the fact that a major medical study would not be possible in a hospital. So, the research facilities are a necessary part of our research community to provide the funding for human cloning. But, the medical research center is also the same type of place where many medical researchers go to learn and to find knowledge. It is possible to develop and test a new type of study that would be more profitable for the research in human cloning. (1) In the following we will detail a practical implementation, one that might cost from $100 to $300.
Practical Implications of Human Cloning
The majority of research in human cloning has come mainly to the point where human cloning technology is far superior to its traditional origins. However, many other developments are also happening. One of these is an advanced gene technology and molecular cloning. Human cloning requires only the presence of a mutation to an allele, or genetic material. The cloning can take many months or years and require large amounts of materials. A mutation is usually a very rare genetic material which means that the exact amount of the genetic material would be far out of range for different organisms. This is possible for several different diseases, as if to take advantage of the information in the genes or the genetic material. This is another aspect of human cloning to be concerned over. Although a significant number of human genetic material have been discovered before, many are not available for human cloning.
The molecular cloning methods require a long process to successfully develop the desired gene. It is important to note that many new approaches to human cloning can be developed with less time. The most important step toward human cloning is probably the use of the first nucleotide substitutions with minimal changes in the DNA polymerase which is used to build the genetic content of the human genetic material. However, this does not necessarily mean that we should develop a new method for human cloning. The molecular cloning also requires that the mutations undergo a longer process than the insertion of the nucleotide. This should not be the case for the insertion of a specific genetic material. In contrast, some of the more common mutations in human genes, for example, certain types of chromosomes, appear very long. So, with the use of some of these mutations in the human genome, the insertion of the first nucleotide substitutions with short distances is very possible.
[Reference]
Kluggus, K. S. “Human Genomic Technology Explained,” pp. 18-27, American Journal of Medicine, August 1990.
[Reference]
Klinich, B., J. W. and C. V. Daugherty, eds. “Human Genome Biotechnology: A Technical Manual,” pp. 20-41, Science, July 2, 1993.
[Reference]
Nunn, K., B. M. Rauchner, R. E. Schmucker, H. K. and A. M. Olinen, “Selected Human Gene Sequencing Project Report,” pp. 24-42, Bioinformatics, May 1989.
[Reference]
Mankowitsch, J., S. M. and H. Nunn, “Selected Human Gene Sequencing Project, U.S. Government Printing Office, 1996.
[Reference]
Olinen, H., G. D. Smith, and J. D. M. Tisdale, “The human genome: The origin and nature of the human species,” Genetics – Volume 7 (February 1996): 2–6. doi:10.1103/Gv700005#95570.
[Reference]
Paule, A., Y. S. Choi, V. S. Choi, and C. V. Daugherty, “Selected Human Genome Research,” Nature, October 28, 2001.
[Reference]